Search results for " must"

showing 10 items of 65 documents

La nueva oportunidad de la hipoteca inversa

2021

The reverse mortgage is a credit or loan guaranteed by a mortgage that falls on the applicant?s habitual residence, granted at once, or through periodic benefits, to a person who must be over a certain age or prove a degree of disability or dependency, and is not due until the time of death. In view of the doubts that the future of the public pension is raising and the concentration of savings in Spanish property, the reverse mortgage is once again being put on the table as a viable alternative to complement a public pension with little revaluation, in view of the increase in life expectancy and expenses after retirement.

:CIENCIAS JURÍDICAS [UNESCO]retirement 160 207viviendaAna Suyapa The reverse mortgage is a credit or loan guaranteed by a mortgage that falls on the applicant?s habitual residenceguaranteejubilaciónto a person who must be over a certain age or prove a degree of disability or dependencyhipoteca inversaor through periodic benefitsthe reverse mortgage is once again being put on the table as a viable alternative to complement a public pension with little revaluationUNESCO::CIENCIAS JURÍDICASreverse mortgagegarantíagranted at onceand is not due until the time of death. In view of the doubts that the future of the public pension is raising and the concentration of savings in Spanish propertyin view of the increase in life expectancy and expenses after retirement. Hipoteca2070-8157 22082 Revista Boliviana de Derecho 565487 2021 31 7730056 La nueva oportunidad de la hipoteca inversa Fernández-Sancho TahocespréstamoloanhousingMortgage
researchProduct

Liquidación de la sociedad de gananciales: el caso de la adjudicación forzosa de participaciones sociales de carácter ganancial a un solo cónyuge. Co…

2021

In a liquidation of community property, the rules for the partition of the inheritance are of suppletive application. Therefore, the sentence opts for a criterion of flexible interpretation of those rules, whose application will be subject to the objective entity of the property in question. Accordingly, when the only property to be shared between the spouses is constituted by set of shares of common nature, taking into account the special circumstances of the case, such shares could be awarded to one of the spouses with the obligation to compensate the other in money, even if it requests the sale of the shares in the public auction. To this end, the request would have to impede the possibi…

:CIENCIAS JURÍDICAS [UNESCO]shares of common nature. 634 649when the only property to be shared between the spouses is constituted by set of shares of common nature2477) Santillán Santa Cruz2070-8157 22082 Revista Boliviana de Derecho 565487 2021 31 7730072 Liquidación de la sociedad de gananciales El caso de la adjudicación forzosa de participaciones sociales de carácter ganancial a un solo cónyuge. Comentario a la sts de españa núm. 458/2020even if it requests the sale of the shares in the public auction. To this endadjudicación forzosa del bien ganancial a un solo cónyugethe request would have to impede the possibility of liquidating the community of property immediatelysale by public auctionpartition of the inheritanceventa en pública subastasuch shares could be awarded to one of the spouses with the obligation to compensate the other in moneyforced allocation of community property to one of the spousesUNESCO::CIENCIAS JURÍDICASde 28 de julio (rj 2020the rules for the partition of the inheritance are of suppletive application. Thereforepartición de la herenciapostponing for longer the state of indivision. There is no requirement that the money must exist in the partible asset. Liquidación de la sociedad de ganancialestaking into account the special circumstances of the casethe sentence opts for a criterion of flexible interpretation of those rulesparticipaciones sociales gananciales.whose application will be subject to the objective entity of the property in question. AccordinglyRomina In a liquidation of community propertyLiquidation of community property
researchProduct

Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study.

2011

To retrospectively assess the efficacy of bendamustine alone and with rituximab (R-B), 109 patients with relapsed chronic lymphocytic leukaemia (CLL) were enrolled in 24 Italian centres. The median age was 66 years (range 39-85). Forty-three percent of patients had relapsed and 57% were resistant (median previous therapies = 3; range 1-8). Twenty-two patients received bendamustine alone and 87 patients received R-B (median B dosage: 100 mg/m(2) per day, range 90-130 mg/m(2) per day). The overall response rate was 69·6% (complete response 28·6%; partial response 41%), and was significantly higher in patients treated with R-B (P = 0·014) and in those responsive to the previous treatment (P=0·…

AdultAged 80 and overMaleAntineoplastic AgentsMiddle AgedLeukemia Lymphocytic Chronic B-CellAntibodies Monoclonal Murine-DerivedTreatment OutcomeDrug Resistance NeoplasmRecurrenceAntineoplastic Combined Chemotherapy ProtocolsNitrogen Mustard CompoundsBendamustine HydrochlorideDrug EvaluationHumanschronic lymphocytic leukemiaFemaleChronic lymphocytic leukemia; bendamustineBendamustinaEpidemiologic MethodsRituximabAged
researchProduct

Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer pr…

2002

The objective of our study was to determine the effect of adding r-metHuSCF to Filgrastim and cyclophosphamide for mobilization of peripheral blood progenitor cells (PBPC), on collection of CD34(+) cells and engraftment after autologous stem cell transplant. Twenty-three patients with previously treated stage II-IV breast cancer received cyclophosphamide (3 g/m(2)), Filgrastim 5 microg/kg daily and r-metHuSCF 20 microg/kg daily. Two PBPC collections were performed on consecutive days starting the day the WBC count was above 7.5 x 10(3)/microl. Collection was performed between days +9 and +12 and the median number of CD34(+) cells collected was 9.9 x 10(6)/kg (1.1-53.1) and 6.6 x 10(6)/kg (1…

AdultCancer Researchmedicine.medical_specialtyFilgrastimPlatelet EngraftmentCyclophosphamidemedicine.medical_treatmentUrologyBreast NeoplasmsFilgrastimTransplantation Autologouschemistry.chemical_compoundInternal medicineGranulocyte Colony-Stimulating FactormedicineHumansNeoplasm MetastasisProgenitor cellCyclophosphamideAgedNeoplasm StagingStem Cell FactorChemotherapybusiness.industryHematologyMiddle AgedHematopoietic Stem CellsHematopoietic Stem Cell MobilizationRecombinant ProteinsNitrogen mustardGranulocyte colony-stimulating factorTransplantationTreatment OutcomeEndocrinologyOncologychemistryLymphatic MetastasisFemalebusinessStem Cell Transplantationmedicine.drugLeukemia
researchProduct

High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell …

2007

On the basis of a preceding phase I study, the current trial explored bendamustine in combination with mitoxantrone and rituximab (BMR) in patients with stage III/IV relapsed or refractory indolent lymphomas and mantle cell lymphoma (MCL) with or without prior rituximab containing chemo-immunotherapy (R-chemo) treatment. Therapy consisted of bendamustine 90 mg/m(2) days 1 + 2, mitoxantrone 10 mg/m(2) day 1, rituximab 375 mg/m(2) day 8. Treatment was repeated on day 29 for a total of four cycles. Between 3 April and 04 July, 57 patients were recruited from 24 participating institutions, 39% of whom had received prior R-chemo therapy. Median age was 66 years (40 - 83). Lymphoma subtypes were …

AdultMaleOncologyBendamustineCancer Researchmedicine.medical_specialtyPathologyPhases of clinical researchLymphoma Mantle-CellAntibodies Monoclonal Murine-DerivedInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineBendamustine HydrochlorideHumansLymphoma FollicularSurvival analysisAgedAged 80 and overSalvage TherapyMitoxantronebusiness.industryLymphoma Non-HodgkinRemission InductionAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseSurvival AnalysisLymphomaClinical trialTreatment OutcomeOncologyNitrogen Mustard CompoundsMonoclonalFemaleRituximabMitoxantroneRituximabbusinessmedicine.drugLeukemia & Lymphoma
researchProduct

Granulomatous slack skin: report of a case associated with Hodgkin's disease and a review of the literature.

1994

We report a case of granulomatous slack skin (GSS) associated with Hodgkin's disease, and review the literature on this entity. GSS, a variant of cutaneous T-cell lymphoma, clinically presents with erythematous patches in the flexures, which gradually transform into bulky, pendulous areas of skin. Histology shows an elastolytic granulomatous infiltrate, with atypical lymphoid cells, and occasional epidermotropism. As far as we are aware, 10 cases of GSS, including our patient, have been reported in detail. The male:female ratio of these cases is 9:1, and the age range 15-51 years. Five cases were associated with Hodgkin's disease, one with small lymphocytic lymphoma, and one developed cutan…

AdultMalePathologymedicine.medical_specialtyAdolescentmedicine.medical_treatmentDermatologychemistry.chemical_compoundMaintenance therapyhemic and lymphatic diseasesmedicineHumansSkinChemotherapyChlorambucilbusiness.industryGranulomatous slack skinMiddle Agedmedicine.diseaseHodgkin DiseaseNitrogen mustardPeripheral T-cell lymphomaLymphomaLymphoma T-Cell CutaneousRadiation therapychemistrybusinessmedicine.drugThe British journal of dermatology
researchProduct

Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas.

1998

Summary Background Ifosfamide has important activity in pretreated soft tissue sarcomas (STS), and recent data support a clinically significant dose-response relationship for this agent. Administration by continuous infusion and hematopoietic support have rendered dose intensification regimens possible by reducing both hematologic and non-hematologic toxicities. The optimal dose and schedule of ifosfamide when given at high doses remain to be defined. In a previous phase I study, we demonstrated the feasibility of a continuous infusion (c.i.) high-dose ifosfamide (HDI) regimen in the ambulatory setting for patients with advanced solid tumors. The objective of the present phase II study was …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentUrologyPhases of clinical researchSoft Tissue NeoplasmsNeutropeniaDrug Administration Schedulechemistry.chemical_compoundGranulocyte Colony-Stimulating FactormedicineHumansIfosfamideInfusions IntravenousAntineoplastic Agents AlkylatingMesnaAgedMesnaChemotherapyIfosfamidebusiness.industrySarcomaHematologyMiddle Agedmedicine.diseaseChemotherapy regimenNitrogen mustardSurgeryRegimenTreatment OutcomeOncologychemistryFemalebusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Effect of a Brassica Juncea Cover Crop on a Mono-Succession of Melon

2013

The ban of methyl bromide and the need for low environmental impact of agriculture has recently increased the interest in the biofumigant effects of Brassica species on soil-borne pathogens. Many researches have tested the toxic effects of Brassica green manures on several soil-borne pathogens in vitro, but field studies have not assessed definitely the efficiency of biofumigation at the field scale and the effect on crop development and production quality. The aim of this research was to evaluate the effect of a winter-spring cover crop of Brassica juncea compared to bare soil on a mono-succession of melon. The biomass of the B. juncea plants or of the weeds eventually developed in bare so…

AgronomyMelonBrassicaEcological successionSettore AGR/04 - Orticoltura E FloricolturaHorticultureBiologygreen manure biofumigation horticulture Brassicaceae Indian mustard crop rotationCover cropbiology.organism_classification
researchProduct

Successful Treatment of Catastrophic Antiphospholipid Antibody Syndrome (CAPS) Associated With Splenic Marginal-zone Lymphoma With Low-molecular Weig…

2008

ABSTRACT Case report A 69-year-old woman with splenic marginal-zone lymphoma was admitted with progressive abdominal pain and splenomegaly as the suspected cause of pain. Rituximab treatment (375 mg/m 2 ) had been initiated on the day of admission. Abdominal computerized tomography revealed splenic infarction. Laboratory tests showed elevation of liver enzymes and creatinine, low platelet count, prolonged partial thromboplastin time, and lupus anticoagulant positivity. The diagnosis of catastrophic antiphospholipid antibody syndrome was made. Weight-adjusted low-molecular weight heparin therapy was initiated. Freedom from symptoms and normalization of liver enzymes and creatinine occurred w…

Bendamustinemedicine.medical_specialtyLymphoma B-Cellmedicine.drug_classLow molecular weight heparinAntineoplastic AgentsGastroenterologyAntibodies Monoclonal Murine-Derivedimmune system diseaseshemic and lymphatic diseasesInternal medicineBendamustine HydrochlorideHumansMedicineSplenic marginal zone lymphomaAgedLupus anticoagulantbusiness.industrySplenic NeoplasmsAnticoagulantAntibodies MonoclonalAnticoagulantsGeneral MedicineHeparinHeparin Low-Molecular-WeightAntiphospholipid Syndromemedicine.diseaseSurgerySplenic infarctionNitrogen Mustard CompoundsFemaleRituximabRituximabbusinessmedicine.drugThe American Journal of the Medical Sciences
researchProduct

Analisi biomolecolare di ceppi di Canine Distemper Virus (CDV) in furetti domestici (Mustela putorius furo)

2011

L’agente eziologico del cimurro (CDV) appartiene alla famiglia Paramyxoviridae, genere Morbillivirus ed è causa di una patologia infettiva e contagiosa in canidi, mustelidi e procionidi. Gli Autori, descrivono un caso clinico di cimurro in due furetti domestici vaccinati con un ceppo Onderstepoort avianizzato. e la caratterizzazione biomolecolare del CDV isolato. I furetti presentavano un quadro clinico caratterizzato da dermatite pruriginosa e squamo-purulenta, alla regione del mento, peri-labiale, peri-vulvare ed al condotto uditivo esterno. I soggetti venivano a morte tre settimane dopo l’esordio dei sintomi. I campioni di croste prelevati sono stati sottoposti ad estrazione degli acidi …

CANINE DISTEMPER VIRUS ANALISI BIOMOLECOLARE MUSTELA PUTORIUS FURO
researchProduct